Journal article
Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.
Abstract
BACKGROUND: Lipid-lowering therapeutics, particularly HMG Co-A reductase inhibitors, can be beneficial in primary and secondary cardiovascular prevention. The Canadian population frequently uses these medications but the manner in which they are used in community-based practice is unknown.
OBJECTIVES: To assess the patient characteristics associated with lipid lowering drug use in community-based clinical practice across four geographic regions …
Authors
Farahani P; Levine M; Gaebel K; LeLorier J; Perreault S; Gillis J; Soon J
Journal
Clinical & Investigative Medicine, Vol. 30, No. 2, pp. e63–e69
Publisher
University of Toronto Press
Publication Date
April 2007
DOI
10.25011/cim.v30i2.981
ISSN
0147-958X